Belyntic

Provides technology for purification and modification of chemically synthesized peptides

placeBerlin, Berlin, Germany calendar_todayFounded 2018 groups3 employees language belyntic.com

Registered entities

Innovation

5 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 63 times.

YearFilings
20171
20181
20191
20202
20214
20221
20241
20252

Investor mix

3 investors on record; lead investors include IBB.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon